Hantz Financial Services’s Solid Biosciences SLDB Stock Holding History

Hantz Financial Services’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7K	Hold	1,000	–	–	﹤0.01%	2122
2025 Q4	$6K	Hold	1,000	–	–	﹤0.01%	2119
2025 Q3	$6K	Hold	1,000	–	–	﹤0.01%	1981
2025 Q2	$5K	Hold	1,000	–	–	﹤0.01%	1765
2025 Q1	$4K	Hold	1,000	–	–	﹤0.01%	1232
2024 Q4	$4K	Hold	1,000	–	–	﹤0.01%	930
2024 Q3	$7K	Hold	1,000	–	–	﹤0.01%	838
2024 Q2	$6K	Hold	1,000	–	–	﹤0.01%	847
2024 Q1	$13K	Buy	1,000 +334	+50%	+$3.13K	﹤0.01%	800
2023 Q4	$4K	Buy	+666	New	+$2.13K	﹤0.01%	955

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return